VRXA
Veraxa Biotech AG Ordinary SharesNASDAQ
Healthcare • Biotechnology
Updated 1 day ago
Coverage limited
$1.20+5.26%
Close Oct 13, 2026
- Market cap
- $169.69M
- 1 month
- -26.4%
- 3 months
- -43.4%
- 1 year
- —
- Dividend
- No dividends on record
- Short interest
- 6.1% of float235K shares · settled Sep 30, 2026 · +12.1% since Sep 15, 2026 · FINRA
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if VRXA is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Holder IQ: MEDIUM
5 top institutions tracked
as of 2026-Q1 (filed 2026-05-15)
Note: 13F filings are reported up to 45 days after quarter-end.Last 13F trend: distributing (heavy)
Unlock crowding heatmapUnlock filer discoveryInsider context
Sentiment: neutral
Last trade: buy 45 days ago
Red flags: 0
Get the Full Analysis for VRXA
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.